DeepComp: AI prediction of complications after stomach cancer surgery
Official title: A Prospective, Multicenter, Observational Study Validating the Multimodal Deep Learning Radiomics Model (DeepComp) for Preoperative Prediction of Major Postoperative Complications in Patients With Gastric Cancer
Run by Hebei Medical University · NCT07401173 · Data updated 2026-11-12
This project will try an AI tool called DeepComp to predict which adults with gastric adenocarcinoma scheduled for curative stomach surgery are at high risk of moderate-to-severe postoperative complications using routine preoperative CT scans and clinical data.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Hebei Medical University Academic / other |
| Locations | 1 site (Shijiazhuang, None Selected) |
| Status | Recruiting |
| Started | March 1, 2026 |
| Main results expected | May 1, 2026 |
| Study ends | May 1, 2026 |
| Registry record updated | April 9, 2026 |
| Trial ID | NCT07401173 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with histologically confirmed gastric adenocarcinoma who are scheduled for elective curative radical gastrectomy and have a standard contrast-enhanced abdominal CT within 14 days before surgery and can provide informed consent.
✕Probably not a fit
Patients undergoing emergency surgery, those found to have unresectable or metastatic disease intraoperatively, recent other malignancies, pregnant or lactating patients, or those with CT scans rendered unreadable by severe metallic artifacts are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, multicenter observational study will enroll adults with histologically confirmed gastric adenocarcinoma who are scheduled for elective radical gastrectomy. Researchers will collect routine preoperative contrast-enhanced abdominal CT scans (venous phase) performed within 14 days before surgery plus standard clinical data, then extract radiomic features and body-composition measures (muscle and fat distribution). The DeepComp AI model will integrate these imaging-derived features with clinical variables to generate preoperative risk predictions for moderate-to-severe postoperative complications. Predicted risks will be compared with actual postoperative outcomes to validate the model's performance across participating centers.
Why it matters
Potential benefit: If successful, DeepComp could help doctors identify patients at higher risk before surgery so perioperative care can be personalized to reduce complications and improve recovery.
How similar studies have gone: Retrospective studies combining radiomics and body-composition metrics have shown promising results for predicting surgical risk, but prospective multicenter validation like this is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Age ≥ 18 years. Histologically confirmed gastric adenocarcinoma. Scheduled for elective radical gastrectomy (open, laparoscopic, or robotic) with curative intent. Standard preoperative contrast-enhanced abdominal CT scans (venous phase) performed within 14 days prior to surgery. Willingness to sign informed consent. Exclusion Criteria: Emergency surgery due to perforation, obstruction, or massive bleeding. Intraoperative findings of distant metastasis (Stage IV) or unresectable disease preventing R0 resection. Concurrent or previous malignant tumors within the last 5 years (except gastric cancer). Pregnancy or lactation. Severe metallic artifacts on CT images preventing radiomic analysis.
Where it's running
-
the Fourth Hospital of Hebei Medical University
Shijiazhuang, None Selected, China Recruiting
Study contacts
- Principal investigator: Qun Zhao — th
- Study coordinator: Ping'an Ding, PhD
- Email: ding_ping_an@hebmu.edu.cn
- Phone: +8631186095363
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
Paclitaxel given inside the abdomen with systemic therapy for GI cancers with peritoneal spread
This phase II study tests a combination of intraperitoneal and systemic chemotherapy (paclitaxel) in adults with digestive tract cancers that have spread to the peritoneum.
-
Axillary Web Syndrome after Breast Cancer Surgery: Incidence, Risk Factors, and Outcomes
This study tests how often AWS occurs after breast cancer surgery and what factors make it more likely, using a forward-looking approach in women undergoing SLNB or ALND.
-
Intraoperative Warmth and Moisture for VATS: Do Humidified Gases Help After Thoracic Surgery?
This observational study looks at whether using heated, humidified gases during VATS with one-lung ventilation helps reduce lung-related postoperative problems.
-
Predicting liver failure after major liver surgery using CT measurements and vascular shape changes
Doctors are testing whether adding vascular deformation mapping to CT measurements can better predict liver failure after removing a large portion of the liver.
-
Hernia Sac Flap Coverage of Mesh in Complex Bony-Edged Ventral Hernias
We’re testing whether using the patient’s own hernia sac as a living flap underneath the mesh helps healing after complex ventral hernia repair when part of the edge is bone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.